Clinical Summary, Knee OA
Study Objective & Methodology
Three 12-week, randomized, double-blind, parallel-group, placebo-controlled, multicenter trials to compare the safety and efficacy of topical diclofenac sodium gel (DSG) for knee OA in patients aged ≥65 years versus 25–64 years
Results
- In patients aged 25–64 years, application of DSG led to around 47% improvement in pain relief and increased mobility up to 45% from baseline
- In patients aged aged ≥65 years, application of DSG led to 44% improvement in pain relief and increased mobility up to 39% from baseline
- DSG provides effective analgesia and potential tolerability benefit with low systemic exposure to adult patients with knee OA pain, regardless of age
Download our study summary below to learn more.
Order Samples
Request Haleon product samples, which are subject to eligibility requirements and availability.
Join Haleon HealthPartner
Get access to professional and patient resources, scientific research, and free patient samples.